Primary small cell carcinoma of the esophagus: progression in the last decade

作者：Anqi Ji, Runsen Jin, Renquan Zhang, Hecheng Li · 发表于：Annals of Translational Medicine · 年份：2020 · DOI：10.21037/atm.2020.03.214 · 被引用次数：33 · 研究领域：Neuroendocrine Tumor Research Advances、Lung Cancer Research Studies、Metastasis and carcinoma case studies

Primary small cell carcinoma of the esophagus (PSCCE) is a highly malignant tumor that is diagnosed by endoscopic biopsy and immunohistochemistry. Because of its low incidence, a high degree of malignancy, and rapid progress, it is difficult to conduct large, randomized controlled trials and to establish a standard treatment plan for this disease. In recent years, several retrospective studies have been reported, and with the rise of emerging therapies, PSCCE has gradually become a focus of thoracic surgery. This paper reviews progress in the diagnosis and treatment of PSCCE in recent years.